Awamu ya 3 Jaribio la AMT-061 Tiba ya Gene kwa Hemophilia B Inazidi Upigaji wa Shabaha

Awamu ya 3 Jaribio la AMT-061 Tiba ya Gene kwa Hemophilia B Inazidi Upigaji wa Shabaha

Habari za Hemophilia Leo

Image

Please enable the javascript to submit this form

Inafadhiliwa na ruzuku za elimu kutoka Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics, na uniQure, Inc.

SSL muhimu